SCHEMBL30764755

SCHEMBL30764755

COC(=O)c1ccc(CN2CC3(C2)CN(C(=O)Cc2ccc(Cl)cc2)C3)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
HSD11B1 P28845 1/20 0.49
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CHKA P35790 1/20 0.44
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 2/20 0.43
LMNA P02545 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MDM2 Q00987 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPK1 P28482 1/20 0.42
LSS P48449 1/20 0.42
DRD2 P14416 2/20 0.42
TBXA2R P21731 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764707 0.83 HSD11B1 (0.55) HPGDHSD11B1KMT2ASMN1; SMN2MEN1
SCHEMBL30764757 0.79 HSD11B1 (0.46) HPGDHSD11B1KMT2ASMN1; SMN2MEN1
SCHEMBL30764735 0.79 HSD11B1 (0.51) HSD11B1KMT2AMEN1ALDH1A1
SCHEMBL30764702 0.78 GHSR (0.46) HSD11B1KMT2AMEN1ALDH1A1
SCHEMBL10899174 0.78 MAPT (0.74) GAAMAPTHPGDKMT2ASMN1; SMN2
SCHEMBL20304895 0.78 HDAC1 (0.53) GAAMAPTHPGDKMT2ASMN1; SMN2
SCHEMBL30764715 0.76 HSD11B1 (0.51) HSD11B1KMT2AMEN1
SCHEMBL30764719 0.76 SMN1; SMN2 (0.53) GAAMAPTHPGDHSD11B1SMN1; SMN2
SCHEMBL10900886 0.74 GAA (0.72) GAAMAPTHPGDKMT2ACHKA
SCHEMBL30764717 0.74 HSD11B1 (0.46) HSD11B1KMT2ASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed